InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Nicklas Westerholm, Chief Executive Officer. Director active across 1 companies, notably Egetis Therapeutics AB (publ). Cumulatively, 1 reports have been recorded. The latest transaction was disclosed on 11 May 2026 — Purchase. Regulator: FIN-FSA. The full history is accessible without signup.
Declarations1 total
0529,761 shares0
Aktie
FI:A003Y632-1·
Ideal exit: 5 Feb 2027 (T+270)
1 of 1 declaration
About Nicklas Westerholm
Nicklas Westerholm is the Chief Executive Officer of Egetis Therapeutics AB (publ). He is responsible for the strategic direction of the company and the management of operations, aiming to promote innovation and growth in the biotechnology sector.
